Meridian Bioscience Preliminary FY2016 Results Miss Analyst Expectations | GenomeWeb

NEW YORK (GenomeWeb) – Meridian Bioscience issued preliminary fiscal year 2016 earnings after the close of the market on Tuesday, reporting a 1 percent year-over-year increase in revenues.

Meridian expects revenues of $196 million for its fiscal year ending Sept. 30, 2016, including fourth quarter revenues of $47 million. Diluted earnings per share should be in the $.75 to $.76 range for the year, compared to $.85 per share in for FY2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.